Advertisement



Drug Recalls

Last updated

Every drug recall in FDA enforcement reports from the last three years, plus older recalls that are still open. Filter by severity, status or medicine, and check the lot numbers on your package.

0 Class I (most serious) drug recalls reported in the last 30 days.

6 recalls

  • Class II Ongoing

    Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-32

    Reason: Presence of Foreign substance – potential presence of metal particulate matter

    F.H. INVESTMENTS, Inc. (dba Asteria Health)

    Lots, distribution and details
    Lots / codes
    Lot#: 254000105, Exp. 05/28/2026, 254000110, Exp. 08/07/2026; 254000112, 254000113, Exp. 09/26/2026.
    Distribution
    Nationwide in the USA
    Quantity
    1,464 pellets.
    Recall started
    January 26, 2026 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0331-2026
  • Class II Ongoing

    Testosterone 75mg, Anastrozole 4mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4079-32.

    Reason: Presence of Foreign substance – potential presence of metal particulate matter

    F.H. INVESTMENTS, Inc. (dba Asteria Health) · Testosterone

    Lots, distribution and details
    Lots / codes
    Lot#: 254000107, Exp. 06/30/2026; 254000111, Exp. 08/07/2026. .
    Distribution
    Nationwide in the USA
    Quantity
    670 pellets
    Recall started
    January 26, 2026 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0327-2026
  • Class II Ongoing

    Testosterone 100mg, Anastrozole 4mg (4.5), 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-01.

    Reason: Presence of Foreign substance – potential presence of metal particulate matter

    F.H. INVESTMENTS, Inc. (dba Asteria Health) · Testosterone

    Lots, distribution and details
    Lots / codes
    Lot#: 254000104, Exp. 05/27/2026
    Distribution
    Nationwide in the USA
    Quantity
    100 pellets
    Recall started
    January 26, 2026 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0326-2026
  • Class II Ongoing

    Testosterone Cypionate/Anastrozole 200mg/1mg/mL, a) 4 mL-vial, b)10mL-vial, Room temperature, Tailor Made Compounding

    Reason: Lack of Assurance of Sterility

    TMC Acquisition LLC dba Tailor Made Compounding

    Lots, distribution and details
    Lots / codes
    Batch#: a)10142123A2, Exp 4/12/2022, 02042202A1, Exp 8/3/2022; b) 10142121A2, Exp 4/12/2022; 10202105A1, Exp 4/18/2022; 11102102A1, Exp 4/30/2022; 02042202A1, Exp 8/3/2022.
    Distribution
    Nationwide USA and Puerto Rico
    Quantity
    106 vials
    Recall started
    March 7, 2022 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1233-2022
  • Class II Ongoing

    Testosterone Cypionate/Anastrozole 200mg/0.5mg/mL, 10mL-vial, Room temperature, Tailor Made Compounding

    Reason: Lack of Assurance of Sterility

    TMC Acquisition LLC dba Tailor Made Compounding

    Lots, distribution and details
    Lots / codes
    Batch#: 11232117A1, Exp 5/22/2022; 01312215A1, Exp 7/30/2022
    Distribution
    Nationwide USA and Puerto Rico
    Quantity
    41 vials
    Recall started
    March 7, 2022 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1232-2022
  • Class II Ongoing

    Anastrozole/Testosterone Cypionate/Propionate 1mg/160mg/40mg/mL, 10 mL-vial, Room Temperature, Tailor Made Compounding

    Reason: Lack of Assurance of Sterility

    TMC Acquisition LLC dba Tailor Made Compounding

    Lots, distribution and details
    Lots / codes
    Batch #: 10182113A1, Exp 4/16/2022.
    Distribution
    Nationwide USA and Puerto Rico
    Quantity
    39
    Recall started
    March 7, 2022 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-1194-2022

Have this medicine at home? Compare the lot number and expiry date on your package with the recall. Do not stop taking a prescribed medicine on your own — stopping suddenly can be riskier than the recalled lot. Your pharmacist can check it and usually swap it for an unaffected one.

What the recall classes mean

  • Class I Most serious: use could cause serious health problems or death.
  • Class II Could cause temporary or medically reversible health problems; serious harm is unlikely.
  • Class III Not likely to cause health problems — for example a labelling or packaging fault.

Source: FDA Enforcement Report, via openFDA. Updated here twice a day; last update October 31, 2026 14:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.

Advertisement